Travere Therapeutics Inc TVTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:25 PM EDT
23.27quote price arrow down-0.90 (-3.74%)
Volume
285,352
52 week range
12.75 - 31.65
Loading...
  • Open23.89
  • Day High24.53
  • Day Low23.25
  • Prev Close24.18
  • 52 Week High31.65
  • 52 Week High Date12/31/21
  • 52 Week Low12.75
  • 52 Week Low Date07/23/21

Key Stats

  • Market Cap1.478B
  • Shares Out63.51M
  • 10 Day Average Volume1.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-24.84

KEY STATS

  • Open23.89
  • Day High24.53
  • Day Low23.25
  • Prev Close24.18
  • 52 Week High31.65
  • 52 Week High Date12/31/21
  • 52 Week Low12.75
  • 52 Week Low Date07/23/21
  • Market Cap1.478B
  • Shares Out63.51M
  • 10 Day Average Volume1.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-24.84

RATIOS/PROFITABILITY

  • EPS (TTM)-3.27
  • P/E (TTM)-7.12
  • Fwd P/E (NTM)-7.29
  • EBITDA (TTM)-152.247M
  • ROE (TTM)-70.84%
  • Revenue (TTM)228.57M
  • Gross Margin (TTM)96.82%
  • Net Margin (TTM)-88.46%
  • Debt To Equity (MRQ)179.85%

EVENTS

  • Earnings Date07/27/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Travere Therapeutics Inc

Profile

MORE
Travere Therapeutics, Inc. is a biopharmaceutical company. It is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its products include Chenodal (chenodiol tablets), Cholbam (cholic acid capsules), and Thiola and Thiola EC (tiopronin tablets). Chenodal, which is for the treatment of patients suffering from gallstones in whom surgery poses an unacceptable health risk due to disease or...
Gary Lyons
Independent Chairman of the Board
Eric Dube Ph.D.
President, Chief Executive Officer, Director
Laura Clague CPA
Chief Financial Officer
Sandra Calvin
Chief Accounting Officer, Vice President, Corporate Controller
Address
3611 Valley Centre Dr, Suite 300
San Diego, CA
92130
United States

Top Peers

SYMBOLLASTCHG%CHG
HSKA
Heska Corp
98.59-2.03-2.02%
ATRS
Antares Pharma Inc
5.60+0.01+0.18%
AMPH
Amphastar Pharmaceuticals Inc
35.08+1.38+4.09%
IRWD
Ironwood Pharmaceuticals Inc
11.44+0.05+0.44%
INVA
Innoviva Inc
16.45+0.16+0.98%